CLLS

#3337
Cellectis S.A. American Depositary Shares
4.28 USD
+19.22%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
4.28
4.28
Range Annuel
1.33
5.48
Changement quotidien
+19.22%
Changement Mensuel
+19.22%
Evolution sur 6 mois
+0.47%
Changement Annuel
+181.58%
Clôture Précédente
3.59
Open
4.28
Bid
Ask
Low
4.28
High
4.28
Volume
4
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 307.1 M
  • Employee 229
  • Founded 1999
  • CEO André Choulika
  • Website www.cellectis.com
  • Headquarter France
  • FIGI BBG0084L1XN2
  • Industry Technology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Cellectis S.A. - American Depositary Shares

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Nouvelles